Cisplatin upregulates mitochondrial nitric oxide synthase and peroxynitrite formation to promote renal injury

Area of Science:

• Mitochondrial Biology
• Nephrology
• Toxicology

Background:

• Cisplatin is a widely used chemotherapy agent with significant nephrotoxicity.
• Nitric oxide (NO) formation is implicated in cisplatin toxicity, but its specific role in mitochondria remains unclear.
• Mitochondrial nitric oxide synthase (mNOS) activation has not been directly linked to cisplatin-induced kidney damage.

Purpose of the Study:

• To investigate the role of mitochondrial nitric oxide synthase (mNOS) upregulation and peroxynitrite formation in cisplatin-associated nephrotoxicity.
• To determine if mNOS activation is a critical event in the development of kidney damage caused by cisplatin.

Main Methods:

• Isolated mitochondrial fractions from kidneys of cisplatin-treated animals.
• Utilized specific inhibitors of neuronal NOS (L-NPA), peroxynitrite scavengers (FeTMPyP), and peroxynitrite donors (SIN-1) in vivo and in vitro.
• Assessed neuronal NOS (nNOS) transcription, nitrite levels, cytoskeleton integrity, and apoptosis.

Main Results:

• Cisplatin treatment upregulated nNOS transcription and increased mitochondrial nitrite levels in kidneys.
• Inhibition of nNOS reduced nitrites, cell death, and cytoskeleton damage.
• Peroxynitrite was identified as a mediator promoting NOS transcription, and its donor mimicked cisplatin's effects.

Conclusions:

• Upregulation of mitochondrial nitric oxide synthase (mNOS) is a key event in the initiation and progression of cisplatin-induced kidney damage.
• Peroxynitrite formation is directly involved in the mechanism of cisplatin nephrotoxicity.
• Targeting mNOS and peroxynitrite pathways may offer therapeutic strategies to mitigate cisplatin-associated kidney injury.